Donor Enriched Activated NK Cell Infusion
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Donor Enriched Activated NK Cell Infusion, covering 2024-09-03 to 2024-09-03. Get the full timeline:
Most recent: Clinical Trial Update: Donor Enriched Activated NK Cell Infusion Post Haploidentical Stem Cell Transplant for Refractory Myeloid Malignancies [Phase 1]